Received Nov 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | YK4C3 | — |
the lyophilized portion of Hiberix was reconstituted using sterile water for injection; the lyophilized portion of Hiberix was reconstituted using sterile water for injection; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received Hib (Hiberix) (batch number YK4C3, expiry date 24-AUG-2026) for prophylaxis. On an unknown date, the patient received Hiberix. On an unknown date, an unknown time after receiving Hiberix, the patient experienced wrong solution used in drug reconstitution (Verbatim: the lyophilized portion of Hiberix was reconstituted using sterile water for injection) and inappropriate dose of vaccine administered (Verbatim: the lyophilized portion of Hiberix was reconstituted using sterile water for injection). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 21-OCT-2025 Nurse called to report in the facility a Hiberix vaccine box was found with only the diluent portion inside. The reporter reported that they suspect that the lyophilized portion of Hiberix was reconstituted using sterile water for injection and administered to a patient; however, no patient had been identified at the moment of the call. No specific patient or other details were available at moment of call since the reporter explained that they had not identify the patient yet.